• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Hypnotic and antinociceptive effects of N3-substituted oxopyrimidines and their mechanism

Research Project

Project/Area Number 15590075
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Biological pharmacy
Research InstitutionHokuriku University

Principal Investigator

KIMURA Toshiyuki  Hokuriku University, Faculty of Pharmaceutical Sciences, Department of Hygienic Chemistry, Associate Professor, 薬学部, 助教授 (20234370)

Co-Investigator(Kenkyū-buntansha) WATANABE Kazuhito  Hokuriku University, Faculty of Pharmaceutical Sciences, Department of Hygienic Chemistry, Professor, 薬学部, 教授 (30113038)
FUNAHASHI Tatsuya  Hokuriku University, Faculty of Pharmaceutical Sciences, Department of Hygienic Chemistry, Research Assistant, 薬学部, 助手 (60343646)
YAMAORI Satoshi  Hokuriku University, Faculty of Pharmaceutical Sciences, Department of Hygienic Chemistry, Research Assistant, 薬学部, 助手 (40360218)
YAMAMOTO Ikuo  Kyushu University of Health and Welfare, School of Pharmaceutical Sciences, Department of Hygienic Chemistry, Professor, 薬学部, 教授 (50069746)
Project Period (FY) 2003 – 2004
Project Status Completed (Fiscal Year 2004)
Budget Amount *help
¥3,100,000 (Direct Cost: ¥3,100,000)
Fiscal Year 2004: ¥1,100,000 (Direct Cost: ¥1,100,000)
Fiscal Year 2003: ¥2,000,000 (Direct Cost: ¥2,000,000)
Keywordsuridine / sleep / antinociceptive effect / nucleoside / uridine receptor / central nervous system
Research Abstract

N^3-Substituted oxopyrimidine nucleosides are known to possess central nervous system depressant effects such as hypnotic activity and antinociceptive effect. We synthesized N^3-substituted oxopyrimidine nucleosides such as benzyl, phenacyl and their related group substituted analogues. N^3-Nitrobenzyl and N^3-(2'-cyanobenzyl)-arabinofuranosyluracil possessed strong hypnotic activity at 2.0 umol/mouse by i.c.v. injection. N^3-(2',5'-Dimethoxyphenacyl)-arabinofuranosyluracil (N^3-(2',5'-DiMeOPhAc)-AraU) was found to exhibit the antinociceptive effects without the hypnotic activity in mice, and the effects was inhibited by naloxone. We report interaction of N^3-(2',5'-DiMeOPhAc)-AraU with opioid receptors using rat brain slice. SD male rat brain slice (20μm) was incubated with opioid ligand with/without N^3-(2',5'-DiMeOPhAc)-AraU. The radioactivity was measured by LSC and FUJI-FL2000. Bindings of [^3H]DAMGO (μ) and [^3H]DPDPE (δ) displaced by 100uM of N^3-(2',5'-DiMeOPhAc)-AraU, while binding of [^3H]U-69593 did not. Apparent decrease of the binding of μ, and δ receptors was recognized in cortex. In addition m receptor in striatum, hippocampus and thalamus was also decreased. These results indicated that antinociceptive effect of N^3(2',5'-DiMeOPhAc)-AraU was partly contributed μ, and δ opioid receptors.

Report

(3 results)
  • 2004 Annual Research Report   Final Research Report Summary
  • 2003 Annual Research Report
  • Research Products

    (2 results)

All 2005 2003

All Journal Article (2 results)

  • [Journal Article] Synthesis of N^3-substituted uridine and related pyrimidine nucleosides and their antinociceptive effects in mice2005

    • Author(s)
      T.Shimizu, T.Kimura, T.Funahashi, K.Watanabe, I.K.Ho, I.Yamamoto
    • Journal Title

      Chem.Pharm.Bull. 53

      Pages: 313-318

    • NAID

      10016652649

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Annual Research Report 2004 Final Research Report Summary
  • [Journal Article] N^3-Phenacyluridine as a new type of antinociceptive compound in mice2003

    • Author(s)
      T.Kimura, T.Shimizu, T.Funahashi, M.Nagakura, K.Watanabe, K.Tachibana, S.Kondo, I.K.Ho, I.Yamamoto
    • Journal Title

      Res.Commun.Mol.Pathol.Pharmacol. 113

      Pages: 57-66

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Annual Research Report 2004 Final Research Report Summary

URL: 

Published: 2003-04-01   Modified: 2018-07-26  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi